Position in ENTA
as of Dec 31, 2025
· filed Feb 11, 2026
Position Value
$1,781,441
+$299,353 QoQ
Shares Held
112,964
-8.8% QoQ
Ownership
0.388%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 78%
Shared 0%
None 22%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025JPMORGAN CHASE & CO holds $15,157,447,129 across 391 Biotechnology names. ENTA ranks #134 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
23,199,512 | $4,037,643,062 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,160 | $3,041,291,289 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,039,481 | $2,738,059,096 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,719,999 | $1,876,907,598 | |
| 5 | NUVL |
Nuvalent, Inc.
|
2,205,251 | $221,826,193 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
2,304,792 | $182,332,089 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,044,642 | $177,589,140 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,423,989 | $152,423,781 |
All Filings in ENTA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1,781,441 | 112,964 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,482,088 | 123,817 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $986,072 | 130,433 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $740,793 | 134,202 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $937,898 | 163,113 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,523,984 | 243,628 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $2,056,341 | 158,546 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $2,410,297 | 138,047 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $1,419,224 | 150,821 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $2,201,983 | 197,134 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $3,915,300 | 182,958 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,760,718 | 167,179 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $8,445,193 | 181,539 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $8,953,954 | 172,623 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,397,704 | 177,654 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $2,815,666 | 39,557 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,785,928 | 37,255 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $2,137,816 | 37,631 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,669,077 | 37,925 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $1,938,621 | 39,307 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,863,051 | 44,253 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $2,099,379 | 45,858 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,372,723 | 47,256 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $2,412,939 | 46,917 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||